AtriCure, Inc. (ATRC) Cash Flow Statement
AtriCure, Inc. (ATRC) generated $64.9M of operating cash flow over the twelve months to 2026-06-30, spent $11.8M on capital expenditure and had free cash flow of $53.1M, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
ATRCAtriCure, Inc.Follow ATRC — free
—
Price chart with a free account
- Market cap
- 3.0B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
| Line | FY2011 Dec 11 | FY2012 Dec 12 | FY2013 Dec 13 | FY2014 Dec 14 | FY2015 Dec 15 | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -2.0 | -1.9 | -5.2 | -21.6 | -7.8 | -15.1 | -8.9 | -4.2 | -15.8 | -19.9 | -13.8 | -22.1 | 4.5 | 12.2 | 57.3 | 64.9 | |
| Capital expenditure | 1.5 | 3.0 | 2.9 | 5.5 | 13.4 | 7.7 | 6.4 | 6.2 | 12.2 | 5.3 | 9.8 | 16.9 | 12.0 | 11.5 | 9.1 | -11.8 | |
| Free cash flow | -3.5 | -4.9 | -8.1 | -27.1 | -21.3 | -22.8 | -15.3 | -10.4 | -28.0 | -25.1 | -23.5 | -39.0 | -7.5 | 0.7 | 48.3 | 53.1 | |
| Stock-based compensation | 2.9 | 3.5 | 3.1 | 7.6 | 9.0 | 11.7 | 14.6 | 16.5 | 18.0 | 22.6 | 28.1 | 28.8 | 35.7 | 40.4 | 44.7 | — |
USD millions · SEC XBRL
AtriCure, Inc. — questions
- What is AtriCure, Inc.'s operating cash flow?
- $64.9M over the twelve months to 2026-06-30.
- How much does AtriCure, Inc. spend on capital expenditure?
- $11.8M over the twelve months to 2026-06-30.
- What is AtriCure, Inc.'s free cash flow?
- $53.1M over the twelve months to 2026-06-30: operating cash flow minus capital expenditure.
Every figure on this page comes from AtriCure, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.